| General Information of This Metabolic Reaction (MR) (ID:
MR009500) |
| Formula |
|
| Reactant |
Ranolazine |
Product |
CVT-2534 |
|
Reactant Info
|
Product Info
|
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
|
Cytochrome P450 2D6 (CYP2D6)
|
DME Info
|
|
Metabolic Type
|
Oxidation
-
N-dealkylation
|
|
|
|
|
|
|
|
| Other MR(s) Related to The Reactant of This MR |
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
|
| Other MR(s) Related to The Product of This MR |
|
Other MR(s) That Metabolize The Produtc of This MR
|
|
|
| References |
| 1 |
Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions
|
| 2 |
Comparison of pharmacokinetic parameters of ranolazine between diabetic and non-diabetic rats
|
| 3 |
Fatal, Intentional Overdose of Ranolazine: Post-Mortem Distribution of Parent Drug and its Major Metabolite
|
| 4 |
Development and validation of a sensitive LC-MS/MS assay for simultaneous quantitation of ranolazine and its three metabolites in human plasma
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.